Evidence Review · Beverage vs extract matters
Green Tea and EGCG: Concentration Changes the Risk
Brewed green tea, matcha, and concentrated green-tea extracts are often treated as interchangeable because they share catechins such as EGCG. They are not interchangeable exposures. The strongest safety concern belongs to concentrated extracts, where liver injury has been documented and no universal “safe below this dose” threshold has been established.
Quick answer
Permanent linkBrewed green tea is generally safe; concentrated green-tea extract has a documented liver-injury signal. EFSA found liver-enzyme concerns at supplemental EGCG intakes of 800 mg/day or above, but could not identify a universally safe supplemental dose below that level [1]. NIH likewise notes that some extracts can cause liver damage, particularly when taken on an empty stomach [2]. Weight-loss effects in randomized-trial meta-analyses are small on average [4,5], so concentrated extract should not be treated like a high-value weight-loss intervention.
Tea, matcha, and extract are different exposure categories
| Form | What evidence supports | Main limitation | Practical interpretation |
|---|---|---|---|
| Brewed green tea | EFSA considers catechins from green-tea infusions generally safe [1]. | Catechin and caffeine content vary; rare liver injury has been reported with very large intake [3]. | Food/beverage context with the strongest safety margin of the forms compared here. |
| Matcha / powdered tea | Whole powdered tea rather than a standardized extract. | Serving composition varies; no universal EGCG-per-serving number or “best form” status applies. | Judge the actual product and serving rather than assuming equivalence to either brewed tea or extract. |
| Concentrated green-tea extract | Clearer liver-safety signal in supplements; ≥800 mg/day EGCG has produced liver-enzyme elevations in trials [1,2]. | EFSA could not establish a universally safe supplemental dose below 800 mg/day [1]. | Do not convert a lower number into a guaranteed-safe threshold. |
Why 800 mg is not a safety target—and 400 mg is not a proven safe line
EFSA reviewed human evidence linking supplemental green-tea catechins to liver effects. At 800 mg/day EGCG, some trials showed initial signs of liver injury, but the agency also emphasized that the available data did not allow a safe supplemental dose below 800 mg/day to be identified [1]. That distinction matters: an observed problem threshold is not the same thing as a validated safe ceiling.
NIH notes that liver damage has been reported with green-tea extracts and that risk may be higher when extracts are taken on an empty stomach [2]. Taking a product with food may change exposure, but it does not turn an arbitrary dose cutoff into a guarantee of safety.
Weight loss: statistically detectable does not mean clinically large
Recent randomized-trial syntheses generally find small average changes in body weight or body-composition measures with green-tea interventions [4,5]. One 2025 meta-analysis reported an average body-weight difference of less than 1 kg, while a 2024 network meta-analysis found small weight effects with low to very-low certainty [4,5]. Different preparations, caffeine content, populations, and trial designs make a single “EGCG burns X% more fat” claim misleading.
That effect size is important for the risk-benefit decision: a concentrated extract with a liver-injury signal should not be sold as though it offers drug-like weight-loss benefit.
Liver-safety boundary
Concentrated extract deserves more caution than a tea beverage
LiverTox documents clinically apparent acute liver injury from green-tea extract and rare reports after very large green-tea intake [3]. Jaundice, dark urine, persistent nausea or vomiting, unusual fatigue, or right-upper-abdominal pain after starting an extract are reasons to stop the product and seek medical evaluation. Existing liver disease, pregnancy, or complex medication use also changes the decision.
Check supplement interactionsSource ledger
References
5 sources
- 01European Food Safety Authority. (2018). Safety of green tea catechins. EFSA concluded green-tea infusions are generally safe; supplemental EGCG at 800 mg/day or above may pose liver concerns, and a safe supplemental dose below that level could not be established. Source →
- 02NIH Office of Dietary Supplements. Dietary Supplements for Immune Function and Infectious Diseases — Green Tea safety section. Notes liver-injury reports and higher risk with some extracts, especially on an empty stomach. Source →
- 03LiverTox. Green Tea. National Institute of Diabetes and Digestive and Kidney Diseases. Clinically apparent liver injury has been linked to green-tea extract and, more rarely, large green-tea intake. PubMed →
- 04Effects of green tea supplementation on obesity indices and adipokines in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. (2025). PubMed →
- 05Comparative effects of tea and coffee drinking on body weight in adults: a systematic review and network meta-analysis of randomized trials. (2024). PubMed →
Frequently asked questions
Is green tea extract safe for the liver?
Green tea extract has a documented liver-injury signal. EFSA found that supplemental EGCG doses at 800 mg/day or above can be associated with liver-enzyme elevations, but importantly could not identify a universally safe supplemental dose below that amount from the available evidence. NIH also notes that some green-tea extracts can cause liver damage, especially when taken on an empty stomach. A fixed internet cutoff should not be treated as a guarantee of safety.
Is brewed green tea safer than green tea extract?
Yes, the safety profile is different. EFSA concluded that catechins from green-tea infusions and similar beverages are generally safe, while concentrated supplements have the clearer liver-safety concern. Rare liver injury has still been reported with large green-tea intake, so “generally safe” is more accurate than “zero risk.”
Does green tea or EGCG cause meaningful weight loss?
The average effect is small. Recent randomized-trial meta-analyses report modest reductions in body weight and related measures, often well under 1-2 kg on average, with low or variable certainty. That is not comparable to an approved weight-loss medicine and does not create a strong reason to accept concentrated-extract risk.
Is matcha automatically safer or better than extract?
Not automatically. Matcha is a powdered tea food rather than the same thing as a concentrated extract, but catechin and caffeine content vary by product and serving. The evidence does not justify a universal “best form” ranking or a fixed EGCG-per-serving assumption for all matcha products.
What symptoms should prompt stopping a green tea extract?
Potential liver-injury symptoms such as jaundice, dark urine, persistent nausea or vomiting, unusual fatigue, or right-upper-abdominal pain warrant stopping the product and seeking medical evaluation. People with liver disease, multiple medicines, pregnancy, or other important health conditions should not treat concentrated green-tea extract as a routine wellness product without review.
Sourcing options
Green-tea extract sourcing examples
Recommendation status
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
Free safety checklist
Get evidence reviews like this
Green tea, EGCG, and liver-safety evidence without invented safe-dose rules.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Editorial reading context
How to read Green Tea and EGCG: Concentration Changes the Risk
Evidence-first green tea and EGCG guide separating brewed tea from concentrated extracts, liver-injury evidence, weight-loss effect size, and why no… This guide is intended to help readers make sense of evidence, safety, and practical fit without turning supplement research into a one-size-fits-all checklist. Use it alongside the linked herb and compound profiles for deeper mechanism and safety details.
For Green Tea and EGCG: Concentration Changes the Risk, focus on whether the evidence matches the exact outcome you care about, whether the dose discussed is realistic, and whether the safety profile fits your medical context. Strong marketing language should carry less weight than human evidence and transparent product quality.
When a page discusses dependence-forming substances, restricted compounds, or high-risk contexts, treat it as harm-reduction education only. It is not a buying guide, dosing instruction, or substitute for professional care.